Immunogenetic markers and seropositivity predict radiological progression in early rheumatoid arthritis independent of disease activity

Journal of Rheumatology

Volumn 28, Issue 4, 2001, Pages 735-744

  Kaltenhauser S ^a   Wagner, U ^a   Schuster, E ^a   Wassmuth, R ^a   Arnold, S ^a   Seidel, W ^a   Troltzsch M ^a   Loeffler, M ^a   Hantzschel H ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Immunogenetics; Prognosis; Rheumatoid arthritis

Indexed keywords

ACUTE PHASE PROTEIN; ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; CHLOROQUINE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GOLD SALT; HLA DR ANTIGEN; HLA DR4 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; METHOTREXATE; PREDNISONE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HUMAN; IMMUNOGENETICS; JOINT DESTRUCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; RHEUMATOID ARTHRITIS; SEX DIFFERENCE;

ADULT; ALLELES; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; BIOLOGICAL MARKERS; COHORT STUDIES; DISEASE PROGRESSION; EPITOPES; FEMALE; GENETIC MARKERS; HLA-DR4 ANTIGEN; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0035088130     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Prognostic criteria in rheumatoid arthritis: Can we predict which patients will require specific anti-rheumatoid treatment?
2. Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis
3. Extraarticular manifestations of rheumatoid arthritis and HLA antigens in northern Italy
4. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis
5. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a follow-up study
6. Destructive arthritis, rheumatoid factor, and HLA-DR4. Susceptibility versus severity, a case-control study
7. Prognostic implications of HLA genotyping in the early assessment of patients with rheumatoid arthritis
8. HLA-DR antigens, Gm allotypes and antiallotypes in early rheumatoid arthritis - Their relation to disease progression
9. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome
10. HLA-DRB1 *0401/0404 genotype and rheumatoid arthritis: Increased association in men, young age at onset, and disease severity
11. Immunogenetic heterogeneity of rheumatoid arthritis
12. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis
13. The acute phase and function in early rheumatoid arthritis. C reactive protein levels correlate with functional outcome
14. HLA-DRB1*04 subtypes are associated with increased inflammatory activity in early rheumatoid arthritis
15. Only high disease activity and positive rheumatoid factor indicate poor prognosis in patients with early rheumatoid arthritis treated with "sawtooth" strategy
16. Radiographic outcome of recent-onset rheumatoid arthritis: A 19-year study of radiographic progression
17. Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort
18. Factors predicting outcome of rheumatoid arthritis: Results of a follow-up study
19. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: A prospective study during the first three years of the disease
20. Prediction of articular destruction in rheumatoid arthritis: Disease activity markers revisited
21. Early rheumatoid arthritis - Onset, course, and outcome over 2 years
22. Etiopathogenesis of the rheumatoid arthritis-like disease in MRL/1 mice. I. The histomorphologic basis of joint destruction
23. Etiopathogenesis of rheumatoid arthritis-like disease in MRL/1 mice. II. Ultrastructural basis of joint destruction
24. Joint inflammation and cartilage destruction may occur uncoupled
25. Clinical improvement and radiological deterioration in rheumatoid arthritis: Evidence that the pathogenesis of synovial inflammation and articular erosion may differ
26. The relationship between synovitis and erosions in rheumatoid arthritis
27. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
28. How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in longterm studies
29. Prediction of erosiveness and rate of development of new erosions in early rheumatoid arthritis
30. Prediction of progression of radiologic damage in newly diagnosed rheumatoid arthritis
31. Lack of association of HLA-DRB1 genotype with radiologic progression in Japanese patients with early rheumatoid arthritis
32. Clinical significance of IgA rheumatoid factor subclasses in rheumatoid arthritis
33. Patterns of radiological progression in early rheumatoid arthritis: Results of an 8 year prospective study
34. Joint erosions and patients with early rheumatoid arthritis
35. Inflammatory patterns in rheumatoid arthritis estimated by the number of swollen and tender joints, the erythrocyte sedimentation rate, and hemoglobin: Longterm course and association to radiographic progression
36. Time lag between active joint inflammation and radiological progression in patients with early rheumatoid arthritis
37. Laboratory markers of disease activity
38. Individual relationship between progression of radiological damage and the acute phase response in early rheumatoid arthritis. Towards development of a decision support system
39. Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritis
40. Prognostic factors in rheumatoid arthritis
41. Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis: Comparative effects of different antigens
42. Combined elevation of IgM andgA rheumatoid factor has high diagnostic specificity for rheumatoid arthritis
43. The influence of HLA-DRB1 genes on desease severity in rheumatoid arthritis